Rocket Pharmaceuticals Inc (RCKT)

SG&A Expense Growth

2.16%

Quarterly · Period ending:

RCKT logo

RCKT SG&A Expense Growth

Latest reported2.16%
RCKT Quarterly SG&A Growth (QoQ) (0.00% → 2.16%)
High-resolution chart · PNG

RCKT sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Rocket Pharmaceuticals Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
2.1575%
16.1604%
-19.9826%
-26.6547%
-12.0439%
12.2706%
-6.5366%
1.9864%
24.4371%
-0.808%
15.873%
6.9702%
9.8022%
-16.9178%
26.0841%
17.5121%
9.2099%
-3.3027%
21.4165%
5.3267%
-12.7829%
33.0691%
43.1239%
-16.0808%
-4.6768%
43.8065%
14.8755%
-1.5217%
15.625%
32.9145%
26.3228%
-44.6829%
-52.6668%
144.1375%
-8.9089%
74.5072%
-22.2029%
4.4792%
18.823%
-0.1728%
-8.2078%
9.2248%
26.5205%
5.6134%
-12.7273%
155.4839%
-8.0664%
153.9157%
104.9383%
97.561%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.